JP2009526552A5 - - Google Patents

Download PDF

Info

Publication number
JP2009526552A5
JP2009526552A5 JP2008555446A JP2008555446A JP2009526552A5 JP 2009526552 A5 JP2009526552 A5 JP 2009526552A5 JP 2008555446 A JP2008555446 A JP 2008555446A JP 2008555446 A JP2008555446 A JP 2008555446A JP 2009526552 A5 JP2009526552 A5 JP 2009526552A5
Authority
JP
Japan
Prior art keywords
amino acid
relt
antibody
hvr
ifn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008555446A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009526552A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/061988 external-priority patent/WO2007117763A2/en
Publication of JP2009526552A publication Critical patent/JP2009526552A/ja
Publication of JP2009526552A5 publication Critical patent/JP2009526552A5/ja
Pending legal-status Critical Current

Links

JP2008555446A 2006-02-13 2007-02-12 Reltをターゲッティングするための方法と組成物 Pending JP2009526552A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77291106P 2006-02-13 2006-02-13
PCT/US2007/061988 WO2007117763A2 (en) 2006-02-13 2007-02-12 Methods and compositions for targeting relt

Publications (2)

Publication Number Publication Date
JP2009526552A JP2009526552A (ja) 2009-07-23
JP2009526552A5 true JP2009526552A5 (cg-RX-API-DMAC7.html) 2010-03-11

Family

ID=38581714

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008555446A Pending JP2009526552A (ja) 2006-02-13 2007-02-12 Reltをターゲッティングするための方法と組成物

Country Status (18)

Country Link
US (1) US20080057066A1 (cg-RX-API-DMAC7.html)
EP (1) EP1984404A2 (cg-RX-API-DMAC7.html)
JP (1) JP2009526552A (cg-RX-API-DMAC7.html)
KR (1) KR20080099264A (cg-RX-API-DMAC7.html)
CN (1) CN101432306A (cg-RX-API-DMAC7.html)
AR (1) AR059447A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007235213A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0706868A2 (cg-RX-API-DMAC7.html)
CA (1) CA2638865A1 (cg-RX-API-DMAC7.html)
CR (1) CR10201A (cg-RX-API-DMAC7.html)
EC (1) ECSP088675A (cg-RX-API-DMAC7.html)
IL (1) IL192957A0 (cg-RX-API-DMAC7.html)
MA (1) MA30265B1 (cg-RX-API-DMAC7.html)
NO (1) NO20083609L (cg-RX-API-DMAC7.html)
RU (1) RU2008136864A (cg-RX-API-DMAC7.html)
TW (1) TW200804418A (cg-RX-API-DMAC7.html)
WO (1) WO2007117763A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200806448B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011022335A1 (en) * 2009-08-21 2011-02-24 Mount Sinai School Of Medicine Of New York University Methods of using cd44 fusion proteins to treat cancer
US20130225503A1 (en) * 2009-09-30 2013-08-29 Baylor Licnensing Group Tex14 peptides as novel antitumor agents
US20130338080A1 (en) * 2012-05-24 2013-12-19 The Trustees Of The University Of Pennsylvania Compositions and methods for treating an activated b-cell diffuse large b-cell lymphoma
KR101966246B1 (ko) * 2015-11-17 2019-04-05 서울대학교산학협력단 FCHo1 조절제를 포함하는 세포 분열 조절용 조성물 및 이를 이용한 세포 분열 조절 방법
CN110913954A (zh) * 2017-03-03 2020-03-24 黑曜石疗法公司 免疫疗法的组合物和方法
EP4149512A4 (en) * 2020-05-12 2024-06-05 Board of Regents, The University of Texas System Methods for treating glioblastoma
CN114209843A (zh) * 2022-01-21 2022-03-22 华中科技大学同济医学院附属同济医院 与relt信号通路有关的抑制剂/激活剂及其应用
CN117362438B (zh) 2023-08-30 2024-04-30 华中科技大学同济医学院附属同济医院 一种抗relt重组单克隆抗体及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859205A (en) * 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
JP2003052374A (ja) * 2001-08-10 2003-02-25 Kirin Brewery Co Ltd 新規樹状細胞膜分子及びそれをコードするdna
US7387271B2 (en) * 2002-12-30 2008-06-17 3M Innovative Properties Company Immunostimulatory combinations
DK1641822T3 (da) * 2003-07-08 2013-07-22 Genentech Inc Heterologe il-17-a/f-polypeptider og terapeutiske anvendelser deraf.
KR20070010046A (ko) * 2004-04-06 2007-01-19 제넨테크, 인크. Dr5 항체 및 그의 용도

Similar Documents

Publication Publication Date Title
US20240368261A1 (en) Compositions and methods for growth factor modulation
ES2363761T3 (es) Procedimientos para el tratamiento de enfermedades autoinmunitarias en un sujeto y en ensayos de diagnóstico in vitro.
RU2008136864A (ru) Способы и композиции для нацеливания на relt
EP3735260B1 (en) Therapeutic peptides and methods for treating autoimmune related disease
WO2015032932A1 (en) Il-18 binding protein (il-18bp) in inflammatory diseases
JP7822577B2 (ja) Cd47を活性化する作用物質およびその炎症治療における使用
JP2011511624A5 (cg-RX-API-DMAC7.html)
WO2023180503A1 (en) Methods for reducing respiratory infections
CN108948203A (zh) 抗pd-1单克隆抗体及其制备方法和应用
GB2493313A (en) Kissorphin peptides for use in the treatment of alzheimer's disease, creutzfeldtjakob disease or diabetes mellitus
CN113874030A (zh) Ards的治疗
EP3256150A1 (en) Thymosin alpha 1 for use in treatment of cystic fibrosis
EP4161576A1 (en) Method of treating or preventing acute respiratory distress syndrome
US20250145994A1 (en) Compositions and methods for treating conditions related to cellular senescence
US20230416381A1 (en) Methods for treating or preventing acute respiratory distress syndrome
US11421025B2 (en) Treatment of IL-17A diseases
WO2021243185A2 (en) Sars-cov-2 binding agents and uses thereof
WO2024053742A1 (ja) コロナウイルス感染症の治療薬
US20040076965A1 (en) MIA-2 protein
CN117255692A (zh) Trem2激动剂生物标志物和其使用方法
CN119654344A (zh) 抗siglec15抗体及其用途
HK40048816A (en) Compositions and methods for growth factor modulation
CN118742563A (zh) 靶向usag-1分子的用于牙齿再生治疗的中和抗体
CN116322738A (zh) 血管加压素-2受体拮抗肽及其用途